AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $25,000 | +66.7% | 1,112 | +81.7% | 0.01% | +33.3% |
| Q4 2018 | $15,000 | +400.0% | 612 | +446.4% | 0.01% | +500.0% |
| Q3 2018 | $3,000 | -25.0% | 112 | -15.2% | 0.00% | -50.0% |
| Q2 2018 | $4,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -69.2% | 132 | -62.1% | 0.00% | -66.7% |
| Q4 2017 | $13,000 | +44.4% | 348 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $9,000 | +28.6% | 348 | -2.2% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | -12.5% | 356 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | +14.3% | 357 | +1.4% | 0.00% | +33.3% |
| Q4 2016 | $7,000 | +16.7% | 352 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $6,000 | +20.0% | 352 | -9.7% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -16.7% | 390 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $6,000 | – | 390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|